KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Convertible Debt (2020 - 2025)

Guardant Health (GH) has disclosed Convertible Debt for 6 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • Quarterly Convertible Debt rose 31.64% to $1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Dec 2025, up 31.64% year-over-year, with the annual reading at $1.5 billion for FY2025, 31.64% up from the prior year.
  • Convertible Debt hit $1.5 billion in Q4 2025 for Guardant Health, up from $1.1 billion in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $1.5 billion in Q4 2025 to a low of $1.1 billion in Q3 2025.
  • Historically, Convertible Debt has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2022.
  • Biggest five-year swings in Convertible Debt: surged 40.75% in 2021 and later decreased 2.39% in 2025.
  • Year by year, Convertible Debt stood at $1.1 billion in 2021, then grew by 0.23% to $1.1 billion in 2022, then grew by 0.23% to $1.1 billion in 2023, then grew by 0.23% to $1.1 billion in 2024, then soared by 31.64% to $1.5 billion in 2025.
  • Business Quant data shows Convertible Debt for GH at $1.5 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.